Clinical Trial Update: Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on Nitrocamptothecin for stage IV prostate cancer that progressed after hormone therapy (study completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Nitrocamptothecin (nitrocamptothecin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED